Short answer: Most longevity treatments are compounded, not FDA-approved — meaning no premarket FDA review of safety, effectiveness, or manufacturing quality. 503A vs 503B determines oversight level; ask which you're getting before you start.
Most longevity treatments — NAD+, sermorelin, tesamorelin from a compounding pharmacy, methylene blue, and others covered in this series — are compounded, not FDA-approved brand-name drugs. That distinction matters more than most people realize, and understanding it actually makes you a better-informed patient, not a more anxious one. Here's what compounding actually means, legally and practically.
What Compounding Actually Is
Compounding is the process by which a licensed pharmacist or physician combines, mixes, or alters drug ingredients to create a customized medication tailored to an individual patient's specific needs — adjusting a dose, removing an allergen, or creating a formulation that isn't otherwise commercially available.
The Single Most Important Fact to Understand
Compounded drugs are not FDA-approved.The FDA doesn't review or verify their safety, effectiveness, or manufacturing quality before they reach a patient — unlike brand-name and generic drugs, which must pass the FDA's formal premarket approval process.[1] This is the foundational fact everything else in this article builds on.
Two Legal Categories, Two Different Oversight Levels
Federal law recognizes two distinct categories of compounders, and knowing which one you're dealing with tells you a lot about the oversight involved.[2]
| 503A | 503B | |
|---|---|---|
| What it is | Licensed pharmacist in a state-licensed pharmacy (or licensed physician) | Larger-scale "outsourcing facilities" |
| Prescription required | Yes — patient-specific prescription is the "hallmark" of 503A | No — can compound for a clinic's general office stock |
| Manufacturing standards | Exempt from CGMP | Must comply with full CGMP requirements |
| FDA inspection | Surveillance/"for-cause" only, not routine | Risk-based scheduled inspections |
| Adverse event reporting | Not required | Required to report serious adverse events to FDA |
| Ingredient sourcing | No requirement to source from an FDA-registered facility | Must source from a registered facility with a certificate of analysis |
| Primary oversight | State boards of pharmacy | FDA |
Both categories are legally prohibited from compounding a drug that's "essentially a copy" of a commercially available FDA-approved drug — unless the prescriber documents that a specific change creates a meaningful clinical difference for that particular patient.[3]
One notable exception worth knowing:503B outsourcing facilities are permitted to compound copies of an FDA-approved drug if that approved drug currently appears on the FDA's official drug shortage list — a provision that's been directly relevant to compounded GLP-1 medications during past shortage periods.
What the FDA Itself Recommends
The FDA has stated this directly and unambiguously: because compounded drugs are held to a lower regulatory standard than approved drugs, they "should only be used to meet the needs of patients whose medical needs cannot be met by an FDA-approved drug."[1] The agency recommends approved drugs be used whenever one is available and appropriate for your situation.
The FDA has also taken enforcement action specifically warning that companies marketing compounded drugs cannot legally claim these products are "the same as" an FDA-approved drug, use the same active ingredient with equivalent clinical proof, or are a generic equivalent — because compounded drugs haven't gone through the same evidentiary review.[4]
Practical Questions Worth Asking Before Starting
The FDA's own compounding guidance points to several genuinely useful questions to bring to a prescriber or pharmacy before starting a compounded longevity medication:
- Is this a 503A or 503B facility? (This determines the applicable oversight level.)
- Is a valid, patient-specific prescription being used?
- Is the bulk drug substance sourced from an FDA-registered facility with a certificate of analysis?
- Is this specific formulation and route of administration legally permitted under the current bulk drug substance rules for that ingredient?
One more practical point worth knowing: unlike FDA-approved drugs, compounded products aren't required to carry standard FDA-reviewed labeling with adequate directions for use. That makes verifying dosing instructions and safety information directly with your prescribing clinician — rather than relying on the product label alone — a genuinely meaningful part of using a compounded medication safely.
Comparing providers? SeeShop by Treatment on RENVA's Longevity hubon RENVA's Longevity hub.
The Bottom Line
Compounding serves a real, legitimate purpose — it's how personalized medications reach patients whose needs a mass-manufactured drug can't meet, and it's the primary way most longevity treatments covered in this series are actually available today. But it operates under a genuinely different regulatory framework than FDA-approved drugs, with less premarket safety review and, for 503A pharmacies specifically, less routine oversight than a fully FDA-regulated manufacturer. That's not a reason to avoid compounded medications — it's a reason to know which type of facility you're working with and ask the right questions before you start.
Sources
- Compounding and the FDA: Questions and Answers — U.S. Food and Drug Administration fda.gov
- Pharmacy Compounding of Human Drug Products Under Section 503A — Guidance for Industry — U.S. Food and Drug Administration fda.gov
- Compounding Laws and Policies — U.S. Food and Drug Administration fda.gov
- FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs — U.S. Food and Drug Administration fda.gov
- Regulatory Framework for Compounded Preparations — NCBI Bookshelf, National Institutes of Health ncbi.nlm.nih.gov
Frequently Asked Questions
Are compounded drugs FDA-approved?
No. Compounded drugs are not FDA-approved — the agency does not review their safety, effectiveness, or manufacturing quality before they reach patients, unlike approved brand-name and generic drugs.
What's the difference between a 503A and 503B pharmacy?
503A pharmacies compound based on a patient-specific prescription and are primarily overseen by state boards of pharmacy. 503B outsourcing facilities compound at larger scale, must follow full FDA manufacturing standards, and are subject to routine FDA inspection.
Is it safe to use a compounded medication?
Compounding serves a legitimate medical purpose, but compounded drugs are held to a lower regulatory standard than FDA-approved drugs. The FDA recommends they be used specifically when an approved alternative can't meet a patient's needs.